Philadelphia gene therapy developer, backed by $250M, makes first acquisition

The company's CEO said the deal will accelerate its efforts to develop a treatment for an aggressive type of brain cancer.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 23, 2020 Category: Pharmaceuticals Authors: John George Source Type: news